ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
WisdomTree Issuer ICAV

WisdomTree Issuer ICAV (WTEE)

11.952
0.032
(0.27%)
Cerrado 02 Diciembre 3:00PM
Realtime Data

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
11.952
Postura de Compra
11.932
Postura de Venta
11.97
Volume Operado de la Acción
2,348
11.88 Rango del Día 12.006
0.00 Rango de 52 semanas 0.00
Precio Anterior
11.92
Precio de Apertura
11.88
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

WTEE Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
JANXJanux Therapeutics Inc
US$ 69.98
(74.17%)
1.19M
SHIMShimmick Corporation
US$ 4.12
(47.14%)
1.9M
CRDOCredo Technology Group Holding Ltd
US$ 64.00
(33.89%)
972.9k
CTORCitius Oncology Inc
US$ 1.3599
(33.32%)
5.25M
VIRVir Biotechnology Inc
US$ 10.26
(25.89%)
412.94k
GELSGelteq Ltd
US$ 3.00
(-21.48%)
223.08k
APMAptorum Group Ltd
US$ 0.67
(-20.71%)
347.79k
INDIindie Semiconductor Inc
US$ 4.48
(-15.15%)
283.55k
SGBXSafe and Green Holdings Corporation
US$ 0.5907
(-13.64%)
715.48k
OMEXOdyssey Marine Exploration Inc
US$ 0.6479
(-13.06%)
1.36M
CTORCitius Oncology Inc
US$ 1.3599
(33.32%)
5.25M
CLSKCleanSpark Inc
US$ 13.79
(-5.03%)
4.35M
SMCISuper Micro Computer Inc
US$ 43.15
(2.74%)
3.28M
TSLATesla Inc
US$ 352.7001
(-1.23%)
3.18M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 22.28
(-2.41%)
3.11M
alertmeipp alertmeipp 2 minutos hace
For the nth time, hope we can move on from Crown and Foley fired.
RVNC
Real McCoy Real McCoy 2 minutos hace
They tried to recapitalize but it failed so they had no choice but to liquidate.
Welcome2Pinkyland Welcome2Pinkyland 2 minutos hace
$KRTL for the win $$
KRTL
11L1 11L1 4 minutos hace
Nov 20, 2024 https://www.sahmcapital.com/news/content/keefe-bruyette-woods-downgrades-federal-national-mortgage-to-market-perform-raises-price-target-to-3-2024-11-20
FNMA
GrandAdmiralThrawn GrandAdmiralThrawn 5 minutos hace
Getting close, My stock pick coming for January, long hold, but sorry guys, I'm looking to control most of the float. So I'll let you know in January.
DjScottyT DjScottyT 5 minutos hace
What an absolute shitshow!
TSOI
getmoreshares getmoreshares 6 minutos hace
don't mind the dips- HATE- LACK of vol!
CGAC
MDA MDA 6 minutos hace
It's the same 5 dumbasses posting.

That is called an, ECHO-CHAMBER.

You dumbass.

Clearly MJ is one too.

Consider your money gone, just like a degenerate gambler.

Me too, only $1500
RNVA
Viewmont Viewmont 8 minutos hace
Only "NO RS" will save us shareholders! Otherwise, us, me, the existing shareholders are/will be screwed big time, and we will be wiped out regardless! (Maybe that was the SANP's goal the hole time.)
I am bulish, hold lots of shares and I hugely just hope that there'll be NO RS.
SANP
XMaster2023 XMaster2023 8 minutos hace
I think you have a typo. Should be 2024 or 2025 not 2026. But it figures, you have never been good with numbers.
NWBO
patrik patrik 8 minutos hace
Agree Longrider,
The source is the problem. HAs anyone ever seen any delay, pause, missed timeline,
or silence from our leader has ever led to anything good from Kim. I can’t think
of any. With Kim at the helm no news has ever been good news. Silence is not
golden with K
KBLB
elks elks 8 minutos hace
Float. 13,295 000. Tic toc.
AZRH
JoJr JoJr 8 minutos hace
I think you're right about that.

They are seriously looking to get into the US Capital Markets and doing it the right way.
RDAR
New money98 New money98 10 minutos hace
Hmmm....is Sofinnova linked to Bioamber??? Just thinking out loud..don't mind me
in99flyers in99flyers 10 minutos hace
1,446,444 holders of Shiba. Up another 1k holders in just a few hours since my last post. This is moving quicker and upward more quickly than I anticipated. Where are all of these new holders coming from? People are lined up to buy Shiba like the welfare line on the 1st and 15th. Let's go.
SHIBUSD
JoJr JoJr 11 minutos hace
Interesting...
Very interesting...

Sargent Schultz...

:)
RDAR
AstroGuru64 AstroGuru64 11 minutos hace
Keefe, Bruyette & Woods analyst Bose George downgrades Federal National Mortgage (OTC:FNMA) from Outperform to Market Perform and raises the price target from $2 to $3.
FNMA
Denisk Denisk 11 minutos hace
Yes That was Karim Mikhail biggest snafu, to go after & try to get approval from the hardest & strictest government regulated Country in all of Europe. I have no idea how much was spent there for nothing, but it must have been very costly to AMRN.
AMRN
INEEDMONEY INEEDMONEY 12 minutos hace
So what's your target here? That's a nice post /trade.
CGAC
XMaster2023 XMaster2023 13 minutos hace
He has not paid more than MUSK!
NWBO
PennyMillions852 PennyMillions852 14 minutos hace
Wow what an ongoing SHITFEST!!!!!!
THBD
jsc52033 jsc52033 15 minutos hace
what symbol do you use to find the vix I can't find it typing vix on schwab they send me into uvxy and uvix
I can't figure out which is the actual vix I'm looking for calls on it
SPY
Rodney5 Rodney5 15 minutos hace
That’s mortgage backed securities MBS’s purchased by the Treasury is exactly what Congress approved in the Charter Act amended by HERA, NOT an illegal commitment fee attached to the illegal Senior Preferred Stock SPS. The United States Treasury does not have the Authority from Congress to collect on
FNMA
12x 12x 15 minutos hace
These appear to be CHMP-requested post-hoc analyses based on pre-specified APOE types, rather than company-initiated ones conducted pre-submission. My concern is that AVXL needs to tread carefully between hypothesis generation and confirmation, especially at this critical drug approval stage. These
AVXL

Su Consulta Reciente

Delayed Upgrade Clock